In a nutshell This review aims to provide guidelines for the management of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL). Some background Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is an uncommon type of Hodgkin lymphoma (HL). It accounts for around 5% of HL cases. The outcomes are usually...
Read MoreGuidelines Posts on Medivizor
Updated NCCN guidelines for pediatric aggressive B-cell lymphomas
In a nutshell This review provided updates to the NCCN guidelines for pediatric aggressive mature B-Cell lymphomas. Some background Pediatric aggressive mature B-cell lymphomas are the most common types of non-Hodgkin lymphoma (NHL) in children. They include Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL). These diseases are...
Read MoreNCCN guidelines for the treatment for patients with classical Hodgkin lymphoma
In a nutshell This article outlined the current guidelines for treatment for patients with classical Hodgkin lymphoma (cHL). Some background Treatments for patients with cHL have advanced in the last number of years and most patients can be cured. Treatment options include chemotherapy (CT), radiotherapy (RT), and biological...
Read MoreOverview of ovarian stimulation for assisted reproduction
In a nutshell This article gives an overview of ovarian stimulation (OS) during assisted reproductive techniques (ART). Some background Many couples with infertility opt to use ART. In vitro fertilization (IVF) is an ART in which eggs are collected and fertilized embryos are implanted in the uterus. The first step of IVF is to cause...
Read MoreManaging patients with chronic myeloid leukemia who fail responding to second generation tyrosine kinase inhibitors
In a nutshell The report recommends how to manage patients with chronic-phase chronic myeloid leukemia (CP-CML) who failed to respond to 2nd generation tyrosine kinase inhibitors (TKIs). The authors suggested to consider patient-specific factors and personalize treatment for such patients. Some background TKIs deactivate cancerous enzymes which cause...
Read MoreUpdate regarding the treatment options for patients with Hodgkin lymphoma
In a nutshell This article reviewed the current treatment options for patients with Hodgkin lymphoma (HL). Some background Treatment options for patients with HL depend on the type of HL, stage of the disease, and the presence of risk factors. The stage of HL represents how widespread or severe the cancer is. Risk factors indicate that there...
Read MoreTreatment recommendations for patients with acute myeloid leukemia.
In a nutshell This article provided treatment recommendations for patients with acute myeloid leukemia (AML). Some background The standard treatment for patients diagnosed with AML is a chemotherapy combination. Once there are no signs of AML (remission), patients are given post-remission chemotherapy to ensure it does not return. However,...
Read MoreWhat biological therapies are recommended for patients with different types of melanoma?
In a nutshell This article reviewed biological therapies for patients with melanoma based on which type of disease they have. Some background Patients with melanoma are often treated with surgery to remove tumors first. In some cases, this is not enough. In other cases, patients have inoperable tumors. These patients are offered...
Read MoreESMO guidelines for acute myeloid leukemia in adult patients
In a nutshell These updated guidelines aim to provide information on managing acute myeloid leukemia in adult patients. Some background The occurrence of acute myeloid leukemia (AML) depends on the age of patients. Case numbers tend to rise significantly in patients aged 60 and over. Therapies for AML in adult...
Read MoreReviewing treatments for unexplained infertility
In a nutshell This review established recommendations for the treatment of unexplained infertility. Some background There is no clear cause for up to 30% of infertility cases. There are several treatment options for these couples. Expectant management uses intercourse to achieve conception. Ovarian stimulation (OS) treatment...
Read MoreNCCN guidelines for children with acute lymphoblastic leukemia
In a nutshell These guidelines aimed to provide information on managing acute lymphoblastic leukemia in pediatric patients. Some background Acute lymphoblastic leukemia (ALL) is the most common cancer in pediatric patients. Advancements in technology have led to improved survival rates for these...
Read MoreNCCN guidelines for acute myeloid leukemia
In a nutshell These guidelines aimed to provide the latest guidelines on managing acute myeloid leukemia. Some background Acute myeloid leukemia (AML) is the most common form of acute leukemia in adults. Recent advances have led to new treatment options for AML such as targeted therapies and low-intensity...
Read More